Dynavax Technologies Corp - Company Profile
Powered by
All the data and insights you need on Dynavax Technologies Corp in one report.
- Save hours of research time and resources with
our up-to-date Dynavax Technologies Corp Strategy Report
- Understand Dynavax Technologies Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Dynavax Technologies Corp (Dynavax) is a clinical-stage biopharmaceutical company that harnesses the power of the human body’s innate and adaptive immune responses through toll-like receptor stimulation to discover and develop novel vaccines and therapeutics. Research and development focus, increase in working capital and marketed product: Heplisav are its strengths, even as, increasing debt could be a major cause of concern. Although high competition, foreign exchange risks, and regulations could negatively impact the company's growth prospects, it could benefit from its regulatory approvals, COVID-19 pandemic and strategic collaborations and growing incidence of cancer.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer